| |
| |
|
| Insider
Information: |
Ruff Shamim |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
31,936 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,045,014 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
31,936 |
|
|
| Total
Value |
$4,045,014 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 107.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sarepta Therapeutics Inc |
SRPT |
SVP, Chief Regulatory ... |
2018-05-22 |
31,936 |
2016-09-22 |
0 |
Premium* |
|
|
Reata Pharmaceuticals Inc |
RETA |
Director |
2023-09-26 |
0 |
2022-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2023-09-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,359) |
0 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2023-07-28 |
4 |
AS |
$164.53 |
$1,354,887 |
D/D |
(8,235) |
7,359 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2023-07-28 |
4 |
OE |
$92.20 |
$759,267 |
D/D |
8,235 |
15,594 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2023-06-07 |
4 |
A |
$93.61 |
$199,951 |
D/D |
2,136 |
7,359 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2023-03-10 |
4 |
S |
$83.73 |
$480,610 |
D/D |
(5,740) |
5,223 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2023-03-10 |
4 |
OE |
$27.32 |
$198,042 |
D/D |
5,740 |
10,963 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2022-01-03 |
4 |
A |
$27.32 |
$3,224 |
D/D |
118 |
118 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Chief Regulatory Affairs |
• – – |
2018-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,432 |
33,241 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Chief Regulatory Affairs |
• – – |
2018-05-22 |
4 |
D |
$89.22 |
$116,432 |
D/D |
(1,305) |
31,936 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Chief Regulatory Affairs |
• – – |
2018-03-15 |
4 |
D |
$81.22 |
$59,778 |
D/D |
(736) |
28,809 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Chief Regulatory Affairs |
• – – |
2018-03-15 |
4 |
OE |
$13.90 |
$59,813 |
D/D |
2,500 |
29,465 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Regulatory Affairs & Qual |
• – – |
2017-11-06 |
4 |
AS |
$55.00 |
$550,000 |
D/D |
(10,000) |
27,045 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Regulatory Affairs & Qual |
• – – |
2017-11-06 |
4 |
OE |
$14.76 |
$147,600 |
D/D |
10,000 |
37,045 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Regulatory Affairs & Qual |
• – – |
2017-10-03 |
4 |
AS |
$50.00 |
$575,000 |
D/D |
(11,500) |
27,045 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Regulatory Affairs & Qual |
• – – |
2017-10-03 |
4 |
OE |
$14.76 |
$169,740 |
D/D |
11,500 |
38,545 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Regulatory Affairs & Qual |
• – – |
2017-08-03 |
4 |
D |
$37.88 |
$109,170 |
D/D |
(2,882) |
27,045 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Regulatory Affairs & Qual |
• – – |
2017-08-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,865 |
29,927 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Regulatory Affairs & Qual |
• – – |
2017-07-21 |
4 |
S |
$44.00 |
$66,000 |
D/D |
(1,500) |
21,062 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Regulatory Affairs & Qual |
• – – |
2017-07-21 |
4 |
OE |
$13.90 |
$83,133 |
D/D |
5,888 |
22,562 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Regulatory Affairs & Qual |
• – – |
2017-07-21 |
4 |
AS |
$44.00 |
$193,072 |
D/D |
(4,388) |
21,062 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Regulatory Affairs & Qual |
• – – |
2017-07-20 |
4 |
OE |
$13.71 |
$85,688 |
D/D |
6,250 |
27,312 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Regulatory Affairs & Qual |
• – – |
2017-07-20 |
4 |
AS |
$42.00 |
$262,500 |
D/D |
(6,250) |
21,062 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Regulatory Affairs & Qual |
• – – |
2017-03-19 |
4 |
D |
$30.30 |
$5,363 |
D/D |
(177) |
21,062 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Regulatory Affairs & Qual |
• – – |
2016-11-08 |
4 |
OE |
$26.24 |
$26,240 |
D/D |
1,000 |
21,239 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, Regulatory Affairs & Qual |
• – – |
2016-09-22 |
4 |
AS |
$60.00 |
$438,660 |
D/D |
(7,311) |
20,239 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
